Longitudinal Cohort Study Center Security Risk Assessment Checklist

A longitudinal cohort study collects information over time, often across multiple visits, systems, staff members, and data-sharing arrangements. This checklist helps you identify privacy and security risks across the full research lifecycle, from enrollment and follow-up through analysis, sharing, retention, and disposal.

Tailor the assessment to your study, institutional policies, and applicable requirements. HIPAA applies to covered entities and business associates handling electronic protected health information; the Common Rule applies to covered research as specified by that policy. A security assessment supports compliance but does not, by itself, establish that a study or organization is compliant.

What participant privacy and confidentiality risks should the assessment cover

Assess whether someone could learn a participant’s identity or infer sensitive facts from records, study communications, or released data. Longitudinal records can become more revealing as visits, health outcomes, dates, locations, family details, and outside datasets accumulate. Consider participant re-identification risk even when direct identifiers have been removed.

• Inventory direct identifiers, such as names and contact details, and indirect identifiers, such as dates, locations, rare diagnoses, family relationships, and distinctive life events.
• Check whether the identity-linking file is stored separately from research data, with access limited to staff who need it.
• Review confidentiality protections in consent materials, including what information may be shared, with whom, and for what purposes.
• Consider privacy risks from participant portals, email, text messages, remote visits, recruitment lists, and communications with family members.
• Review planned data access, sharing, secondary use, data-use agreements, and institutional policies on retention and destruction.

For research subject to the Common Rule, the IRB must consider whether adequate provisions protect participant privacy and data confidentiality. The consent process must also describe the extent to which confidentiality of identifying records will be maintained. See 45 CFR 46.111 and 45 CFR 46.116.

How should research data sensitivity and breach likelihood be evaluated

Classify information by how much harm its exposure, alteration, loss, or unavailability could cause. Consider both the sensitivity of individual fields and the risk created when records are combined across study waves or linked to external information. Examples that may warrant heightened attention include genetic or biometric information, precise location, detailed health histories, and information about stigmatized conditions or vulnerable circumstances.

Estimate risk by evaluating plausible threats, the weaknesses they could exploit, the likelihood of occurrence, and the potential impact on participants and study operations. Record the assumptions behind your ratings and consider both inherent risk before safeguards and residual risk after existing safeguards are accounted for. HHS guidance describes risk analysis as identifying threats and vulnerabilities, assessing current safeguards, and determining risk levels and corrective actions. See HHS OCR’s HIPAA Security Rule risk analysis guidance.

For an impermissible use or disclosure of PHI, the HIPAA Breach Notification Rule uses a separate breach assessment. The assessment must consider the nature and extent of the PHI, including the likelihood of re-identification; who received or used it; whether it was actually acquired or viewed; and how the risk was mitigated. Do not treat this incident-specific test as a substitute for the center’s broader, proactive risk assessment. See the HHS Breach Notification Rule guidance.

Which study procedures may increase participant risk

Review each procedure that creates, uses, moves, links, or retains participant information. A procedure may introduce risk even when the research activity itself is routine, particularly if it involves new systems, external partners, or repeated contact over many years.

• Recruitment, eligibility screening, consent, and recording contact preferences.
• Repeated questionnaires, clinical visits, home visits, remote interviews, and participant-facing apps or devices.
• Collection, labeling, storage, transport, and analysis of biospecimens or linked clinical records.
• Transfer of data to collaborators, sponsors, laboratories, cloud services, or repositories.
• Linkage with public records or other datasets, which may increase identification risk even if direct identifiers are removed.
• Retention, archival access, secondary use, participant withdrawal, and final data or device disposal.

For every step, ask what information is collected, who can see it, where it is stored, how it is transmitted, and what happens if a device or account is lost or compromised. NIH guidance notes that data sharing can create re-identification risks and recommends considering those risks and protections with participants during the informed-consent process. See NIH data-sharing approaches.

How to identify assets threats vulnerabilities and existing controls

Build an inventory that follows information through the study rather than focusing only on the central database. Include paper records, identity keys, databases, laptops, mobile devices, servers, backups, cloud services, lab systems, file-transfer tools, and third-party services that create, receive, maintain, or transmit research information.

• Assets: Record the data, systems, devices, facilities, accounts, and services that support study operations.
• Data flows: Map collection, storage, access, transfers, analysis, backup, retention, and disposal, including transfers to external partners.
• Threats: Consider unauthorized access, phishing, ransomware, accidental disclosure, device loss, insider misuse, service outages, fire, and other environmental events.
• Vulnerabilities: Look for excessive permissions, unpatched systems, unsecured transfers, weak account recovery, shared credentials, exposed paper files, and incomplete staff offboarding.
• Existing controls: Record safeguards already in place and verify that they are used and working as intended.

HHS guidance calls for identifying reasonably anticipated threats and vulnerabilities, documenting current safeguards, and recording risk levels and corrective actions. See HHS OCR’s risk analysis guidance.

What security safeguards should research centers verify

Verify administrative, physical, and technical safeguards against the study’s risks. If HIPAA applies, use the Security Rule’s standards and implementation specifications to guide the review; some specifications are “addressable,” which requires an appropriate assessment and documentation rather than automatic omission. Select safeguards based on the center’s environment, the information involved, and reasonably anticipated threats.

• Access management: Confirm role-based access control is aligned with job duties, access is approved and reviewed, and staff receive only the permissions they need. Use unique accounts and remove or change access promptly when roles change or work ends.
• Encryption: Verify research data encryption at rest and in transit where appropriate, including on portable devices, backups, and approved transfer channels. Under HIPAA, encryption specifications are addressable, so document the decision and any equivalent alternative safeguards.
• Monitoring: Review audit logs, access reports, unusual login activity, and alerts for sensitive systems.
• Account protection: Check authentication, password management, session controls, and protection against malicious software.
• Physical security: Inspect access to offices, file rooms, laboratories, servers, and paper records; confirm secure storage and disposal practices.
• Resilience and response: Verify retrievable backups, recovery procedures, incident reporting channels, and tested plans for disruptions.
• Third parties: Review vendor access, contracts, data-use terms, security assurances, and the process for reporting incidents.

The HIPAA Security Rule specifies access control, unique user identification, audit controls, authentication, and transmission security, and includes addressable encryption specifications. It also requires covered entities and business associates to implement appropriate administrative safeguards, including workforce access and termination procedures. See 45 CFR 164.312 and 45 CFR 164.308.

How to document mitigation actions and follow-up

Maintain a dated record of the assessment, including its scope, systems and data reviewed, participants in the review, identified risks, likelihood and impact ratings, existing controls, and assumptions. Keep the record specific enough that another reviewer can understand how the center reached its conclusions.

For each risk requiring action, document the mitigation, responsible owner, target date, resources or dependencies, approval, and method for verifying completion. Record whether the risk is reduced, accepted by an authorized decision-maker, transferred, or still open, and assign a review date for unresolved or accepted risks.

Connect the assessment to the research data breach response process. Staff should know how to report suspected incidents, who leads the response, how evidence and records will be preserved, and how the center will assess potential participant impact. Where HIPAA applies, covered entities and business associates must identify and respond to suspected or known security incidents, mitigate harmful effects where practicable, and document incidents and outcomes. See 45 CFR 164.308 and the HHS Breach Notification Rule guidance.

When should a longitudinal cohort study center repeat its risk assessment

Repeat or update the assessment when meaningful changes could alter risk. Examples include adding a new collection method, opening a data repository, introducing a vendor or cloud service, linking a new dataset, changing access roles, expanding to a new site, or responding to an incident or control failure. Reassess when study procedures, consent terms, applicable requirements, or the threat environment change in ways that affect participant information.

For organizations subject to HIPAA, the Security Rule requires risk analysis and a periodic technical and nontechnical evaluation, including evaluation in response to environmental or operational changes affecting ePHI security. It does not set a single fixed annual interval for every risk analysis. Establish and document a review cadence suited to the study’s risk, and perform an update sooner when a significant change or incident warrants it. See 45 CFR 164.308.

In short, a useful assessment connects participant privacy risks to real data flows, verifies that safeguards operate as intended, and assigns owners and follow-up dates to mitigation actions. Revisit it as the cohort, its systems, and its partnerships evolve.

FAQs

How often should a longitudinal cohort study center conduct a security risk assessment?

There is no single fixed annual interval for HIPAA risk analysis. If HIPAA applies, the center must conduct an accurate and thorough risk analysis and perform periodic technical and nontechnical evaluations, including when relevant environmental or operational changes occur. Set a documented review schedule based on the study’s risks and update sooner after material changes or incidents.

What participant information could create legal financial employment or reputational harm if disclosed?

Potentially sensitive information can include detailed health histories, genetic or biometric data, precise location, contact details, family relationships, financial or employment information, and records about stigmatized conditions. Combinations of dates, rare diagnoses, locations, and life events may also make a participant identifiable even without a name. The likely harm depends on the person’s circumstances, the information exposed, and who receives it.

Which security controls help protect identifiable longitudinal research data?

Use layered safeguards: role-based access control, unique user accounts, timely access reviews and research staff data access offboarding, encryption at rest and in transit where appropriate, audit logging, secure backups, physical protections, staff training, and a tested incident response process. Choose controls based on the study’s data flows and risks, and verify that they are effective rather than relying on policy documents alone.

When should a study center update its risk assessment?

Update it when study procedures, information systems, data-sharing arrangements, vendors, access permissions, or participant data change in a way that could affect security or confidentiality. Also review it after a security incident, a significant control failure, or a change in applicable requirements. Record what changed, how the change affects risk, and any resulting mitigation actions.